Vaccinium bracteatum Thunb. fruit extract reduces high-fat diet-induced obesity with modulation of the gut microbiota in obese mice.

Abstract

Vaccinium bracteatum Thunb. fruits have been used as traditional food. This study investigated the effects of a polyphenol-rich Vaccinium bracteatum Thunb. fruit extract (VBTE) on obesity and obesity-related diseases in mice, and the potential role of the gut microbiota in the bioactivity of VBTE was also determined. Chemical constituents of the VBTE were analyzed by liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS/MS). C57BL/6J mice (weighing 17.8-21.6g) were fed a low-fat diet (LFD) or high-fat diet (HFD) with or without VBTE treatment for 14weeks. The gut microbial changes were determined using 16S rRNA sequencing. Our results showed that VBTE mainly contains 36 kinds of polyphenols. VBTE reduced HFD-induced body weight gain by 33.42% (p<.05), steatosis scores by 56.25% (p<.05), and insulin resistance index by 51.49% (p<.05). Moreover, VBTE altered the composition of the gut microbiota. The correlation analysis indicated that Akkermansia, Alistipes, Bacteroides, Alloprevotella, Ruminiclostridium, Ruminiclostridium_9, and Rikenellaceae_RC9_gut_group were negatively correlated with serum lipids, glucose, and insulin, while Escherichia-Shigella was positively associated with these clinical indicators. In conclusion, VBTE supplement could reduce obesity and be a treatment option for obesity-related diseases by influencing the gut microbiota in mice. PRACTICAL APPLICATIONS: Plant extracts are widely used to treat obesity and related metabolic disorders. Polyphenols, the well-known natural antioxidants present in fruits, are consumed as a dietary supplement to prevent many diseases. Recent pharmacological studies have reported that Vaccinium bracteatum Thunb. fruits have many physiological functions, such as anti-proliferative, anti-inflammatory, and antidepressant-like effects. Despite these properties of Vaccinium bracteatum Thunb. fruits, their anti-obesity effect has not been studied to date. The findings of this study will support VBTE could be used as an important therapeutic application for preventing obesity and related metabolic diseases by modulating the gut microbiota.